INVESTIGATING THE ANTIFUNGAL SUSCEPTIBILITY PATTERN OF CANDIDA ALBICANS ISOLATED FROM DIFFERENT CLINICAL SAMPLES BY KIRBY-BAUER DISC DIFFUSION AND BROTH MICRODILUTION METHOD TO FLUCONAZOLE AND AMPHOTERICIN B

Main Article Content

Shrawan Kumar
Nilam Nigam
Kalpana Kuntal
Nashra Afaq
Saif Anees
Vinay Shekhar Srivastava

Keywords

Candida albicans, Antifungal Susceptibility, Antifungal resistance, Disc diffusion method, Microdilution method

Abstract

Introduction: Candidiasis is a severe fungal infection caused mostly by Candida albicans in humans.  Candida albicans is an opportunistic infection in immunocompromised persons that has proven lethal despite antifungal treatment. The rise in antibiotic resistance in C. albicans is alarming, as it is in the human microbiome.


Aim and Objective: To detect the antifungal sensitivity pattern of Candida albicans isolated from various clinical samples to Fluconazole and Amphotericin B using the Kirby Bauer disc diffusion method and the Broth microdilution method.


Materials and Methods: This was a cross sectional study carried out in the Department of Microbiology at a tertiary care centre, Uttar Pradesh for a period of 1 year i.e,  January 2023  to January 2024. A total of 75 isolates of Candida species from different clincal specimens like blood, BAL, urine, Pus, Et secreation and vaginal secreation were evaluated for its susceptibility against Fluconazole and Amphotericin B using Kirby Bauer disc diffusion method and Broth micro dilution method according to the CLSI guidelines 2023.


Results: In the present study out of 75 isolates of Candida species 30 (40%) isolates were confirmed to be C.albicans. The ratio of Males 19 (63.3%) was more as compared to that of the Females 11( 36.6%) with the maximum age of  31-40 being affected the most followed by 41-50 and least in the age group above 61 years of age. The number of isolates was maximum in the urine sample with 50%.  


Out of 75 isolates a total of 30 isolates of Candida albicans were isolated. A total of 13 (43.3%) samples of Candida were sensitive and 17 (56.6%) samples were resistant to Amphotericin B and 27(90%) samples of Candida were sensitive and 3(10%) samples were resistant to Fluconazole by Kirby bauer disc diffusion method.93.3% were sensitive whereas 2 (6.6%) were resistant against Amphotericin B and 25 isolates(83.3%) were sensitive and 5 isolates (16.6%) were resistant to Fluconazole by  broth microdilution method.


Conclusion:


The Antifungal susceptibility testing by broth microdilution method revealed that fluconazole was exceedingly resistant against Candida albicans (16.6%) and increasingly susceptible to Amphotericin B( 93.3%). Antifungal susceptibility testing could be used to predict clinical response or management failure. As a result, proper antifungal drug administration should only be prioritised after susceptibility testing.

Abstract 122 | PDF Downloads 51

References

1. Almeida AA, Mesquita CS, Svidzinski TI, Oliveira KM. Antifungal susceptibility and distribution of Candida spp isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop. 2013; 46(3):335–9.
2. Almeida AA, Mesquita CS, Svidzinski TI, Oliveira KM. Antifungal susceptibility and distribution of Candida spp isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop. 2013; 46(3):335–9.
3. Yenisehirli G, Bulut N, Yenisehirli A, Bulut Y. In vitro susceptibilities of Candidaalbicans isolates to antifungal agents in Tokat, Turkey. Jundishapur J Microbiol. 2015; 8(9):e28057.
4. Badiee P, Alborzi A, Shakiba E, Farshad S, Japoni A. Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents. East Mediterr Health J. 2011; 17(5):425–30
5. Aydin E, Karakas A, Savasci U, Akpak YK, Caymaz SO, Avci SAM, et al. Identification of Candida species isolated from clinical samples and investigating antifungal susceptibility in Turkey. Acta Med. 2014; 30:561
6. Camila G Freitas , Maria Sueli Felipe. Candida albicans and Antifungal Peptides. Infect Dis Ther. 2023; 12(12):2631-2648.
7. Clinical and Laboratory Standards Institute (CLSI).Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, 3rd ed. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA. 2023.
8. L. Sherry, R. Kean, E. McKloud et al., “Biofilms formed by isolates from recurrent vulvovaginal candidiasis patients are heterogeneous and insensitive to fluconazole,” Antimicrobial Agents and Chemotherapy. 2017; vol. 61, no. 9.
9. R A Kashid S Belawadi G Devi D Dadich Characterization and antifungal susceptibility testing for Candida species in a tertiary care hospital J Health Sci Res 20112217
10. C S Amar Ashish J V Hajare Y Belagali Study of prevalence and antifungal susceptibility of candidaInt J Pharm Bio Sci. 2013; 4236181

11. Sailaja B, Prasad P. A study on isolation of Candida species in various clinical samples in a tertiary health care unit. Indian Journal of Microbiology Research. 2019; 6: 258-260.
12. Chitralekha Saikumar A. Arasi Samyuktha Isolation, Identification and Speciation of Candida Species from Various Clinical Specimens in a Tertiary Care Hospital in ChennaiSch J App Med Sci201758F34608 .019;ndian Journal of Micro2biology Research.
13. F lvarez-Lerma J Nolla-Salas C Len M Palomar R Jord N Carrasco Candiduria in critically ill patients admitted to intensive care medical units Intensive Care Med 2003297106976.
14. C A Kauffman Candiduria Clin Infect Dis . 2005413717Supplement 6
15. Sankarankutty Jay Vipparti Harita Candida Species Isolated from Various Clinical Samples and their Susceptibility Patterns to Antifungals. J Med Microbiol Infec Dis. 201311226.
16. Kamal Uddin Zaidi,AbiniMani,VijayThawani,ArtiMehra.Total Protein Profile and Drug Resistance in Candida albicansisolated from clinical samples.Mol Bio Int 2016; 2016:4982131.doi:10.1155/2016/4982131
17. Lulu Zhang,XiaodongShe,Daniel Merenstein et.al.Fluconazole Resistance patterns in Candida species that colonize women with HIV infection.Current Therapeutic research. 2014; 76(C):84-89.
18. Lamsal,S.,Adhikari,S.,Raghubhansi,B.R.,Sapkota,S.,et.al Antifungal Susceptibility and Biofilm formation of Casndida albicans isolated from different clinical specimens.Tribhuvan University Journal of Microbiology,8(1),53-62.https://doi.org/10.3126/tujm.v8.41195.
19. Rathod SD,KlausnerJD,KruppK,ReingoldAL,AdhivananP.Epidemiologic features ofv Vulvovaginal Candidiasis among Reproductive Age women in India. Infect Dis Obst Gynaecol. 2012 ;2012:859071.
20. Henry,K.W.,Nickels,J.T.,Edlind,T.D. Upregulation of Erg Genes in Candida Species by Azoles and other sterol Biosynthesis Inhibitors. Antimicrob.Agents chemother 2000; .44: 2693-2700.doi:10.1128/AAC.44.10.2693-2700.2000 .
21. Fadda ME, Podda GS, Pisano MB, Deplano M, Cosentino S. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: Results of a three year survey. J Prev Med Hyg 2008; 49(2):69-74.
22. Shokohi T, Bandalizadeh Z, Hedayati MT, Mayahi S. In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents. Jundishapur J Microbiol. 2011; 4(Suppl 1):S19–26.
23. Badiee P, Alborzi A, Shakiba E, Ziyaeyan M, Rasuli M. Molecular identification and in-vitro susceptibility of Candida albicans and C dubliniensis isolated from immunocompromised patients. Iran Red Crescent Med J. 2009; (4):391–7
24. Pellon A., Begum N., Nasab S.D.S., Harzandi A., Shoaie S., Moyes D.L. Role of Cellular Metabolism during Candida-Host Interactions. Pathogens. 2022; 11:184.
25. Nazir A, Masoodi T. Spectrum of Candida species isolatedfrom neonates admitted in an Intensive Care Unit of teachinghospital of Kashmir, North India. Journal of LaboratoryPhysicians. 2018; 10 (3):255-259.

Most read articles by the same author(s)